Market Research Report
Global Active Pharmaceutical Ingredients Market 2021-2025
|Global Active Pharmaceutical Ingredients Market 2021-2025|
Published: January 28, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
Technavio has been monitoring the active pharmaceutical ingredients market and it is poised to grow by $ 64.53 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on the active pharmaceutical ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the evolving API manufacturing scenario in developing countries and the growing need to focus on core competencies. In addition, evolving API manufacturing scenario in developing countries is anticipated to boost the growth of the market as well.
The active pharmaceutical ingredients market analysis includes type segment and geographical landscapes.
Technavio's active pharmaceutical ingredients market is segmented as below:
This study identifies the Increasing number of type II DMFs as one of the prime reasons driving the active pharmaceutical ingredients market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the active pharmaceutical ingredients market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients market vendors that include Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., GlaxoSmithKline Plc, Koninklijke DSM NV, Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.